The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•8 June 2026•

2 min read

Goldman Sachs Initiates BrightSpring Health at Buy with $71 Price Target

Key Facts

1Goldman Sachs analyst Scott Fidel initiated coverage on BrightSpring Health with a Buy rating and a price target of $71.00.

2BrightSpring Health shares have rallied 56.2% year-to-date, supported by strong growth in its Provider Services segment.

3The company expanded its network through strategic acquisitions of major providers including Amedisys and LHC Group.

Amid growing institutional interest in the home healthcare sector, Goldman Sachs analyst Scott Fidel has initiated coverage on BrightSpring Health with a 'Buy' rating. The analyst set a price target of $71.00, signaling significant upside potential for the stock. Shares have already rallied 56.2% year-to-date, driven by robust performance in the Provider Services segment and the strategic expansion of its network through the acquisitions of major providers such as Amedisys and LHC Group.

This optimistic outlook arrives as the healthcare services sector undergoes structural shifts toward community-based care, with firms competing for market share through consolidation. Looking at peers, recent earnings reports from companies like Humana and UnitedHealth show a similar pivot toward strengthening home-care services to reduce costs. Per market data, BrightSpring's current valuation reflects investor confidence in its ability to successfully integrate new acquisitions and deliver sustained revenue growth.

Technically, BrightSpring Health (BTSG) shares are trading at $57.40 (close June 8, 2026), placing the Goldman Sachs target approximately 23.7% above current levels. Traders should monitor upcoming US employment data, as labor costs directly impact margins for healthcare providers. Additionally, the JOLTs Job Openings report, which showed 7.618 million openings (data as of June 2, 2026), provides critical context regarding the labor market conditions the company faces.